STABILITY INDICATING LIQUID CHROMATOGRAPHIC METHOD FOR THE QUANTITATIVE DETERMINATION OF RUFINAMIDE IN PHARMACEUTICAL DOSAGE FORMS
A selective, specific and sensitive stability-indicating high-performance liquid chromatographic method was developed and validated for the determination of Rufinamide in tablet dosage forms. Reversed-phase chromatography was performed on Shimadzu Model CBM-20A/20 Alite, equipped with SPD M20A prominence photodiode array detector using C18 column (250 mm Ã— 4.6 mm, 5 Î¼m) with a flow rate of 1.0 mL/min.Â Detection wavelength was 210 nm and temperature was 30Â°C.Â Linearity was observed in the concentration range of 0.01â€“160 Î¼g/mL with regression equation y = 112887 x + 35285 with correlation coefficient of 0.9998. The LOD and LOQ were found to be 0.0086 Î¼g/mL and 0.0028 Î¼g/mL respectively. The percentage relative standard deviation in precision and accuracy studies was found to be less than 2%. Rufinamide was subjected to stress conditions of degradation in aqueous solutions including acidic, alkaline, oxidation, photolysis and thermal degradation and it was found that the drug is highly resistant towards all degradations as the decomposition was less than 1.5%. The developed method was validated with regard to linearity, accuracy, precision, selectivity and robustness and the method was found to be precise, accurate, linear and specific. Â As the proposed LC method achieved satisfactory resolution between Rufinamide, its degradation products, intermediate product possibly present in Rufinamide drug substance and other impurities in the end product before refining in the final step of synthetic process, it can be employed as a stability indicating one, used for the synthetic process control and determination of Rufinamide in pharmaceutical preparations.
Keywords: Rufinamide, Isocratic elution, RP-HPLC, Validation, Stability-indicating, LOD, LOQ.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).